{"id":"https://openalex.org/W1995337670","doi":"https://doi.org/10.1053/j.ajkd.2011.02.208","title":"205 Discovery and Development of Bardoxolone Methyl, an Antioxidant Inflammation Modulator (AIM) Targeting the KEAP1-NRF2 Pathway","display_name":"205 Discovery and Development of Bardoxolone Methyl, an Antioxidant Inflammation Modulator (AIM) Targeting the KEAP1-NRF2 Pathway","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W1995337670","doi":"https://doi.org/10.1053/j.ajkd.2011.02.208","mag":"1995337670"},"language":"en","primary_location":{"id":"doi:10.1053/j.ajkd.2011.02.208","doi":"https://doi.org/10.1053/j.ajkd.2011.02.208","is_oa":false,"landing_page_url":"https://doi.org/10.1053/j.ajkd.2011.02.208","pdf_url":null,"source":{"id":"https://openalex.org/S18197459","display_name":"American Journal of Kidney Diseases","issn_l":"0272-6386","issn":["0272-6386","1523-6838"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Kidney Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088903572","display_name":"Colin J. Meyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143032186","display_name":"Reata Pharmaceuticals (United States)","ror":"https://ror.org/02jqp5961","country_code":"US","type":"company","lineage":["https://openalex.org/I143032186"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin J. Meyer","raw_affiliation_strings":["Reata Pharmaceuticals, Inc., Irving, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reata Pharmaceuticals, Inc., Irving, TX, USA","institution_ids":["https://openalex.org/I143032186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042762813","display_name":"W. Christian Wigley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143032186","display_name":"Reata Pharmaceuticals (United States)","ror":"https://ror.org/02jqp5961","country_code":"US","type":"company","lineage":["https://openalex.org/I143032186"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Christian Wigley","raw_affiliation_strings":["Reata Pharmaceuticals, Inc., Irving, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reata Pharmaceuticals, Inc., Irving, TX, USA","institution_ids":["https://openalex.org/I143032186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110168","display_name":"Deborah A. Ferguson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143032186","display_name":"Reata Pharmaceuticals (United States)","ror":"https://ror.org/02jqp5961","country_code":"US","type":"company","lineage":["https://openalex.org/I143032186"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah A. Ferguson","raw_affiliation_strings":["Reata Pharmaceuticals, Inc., Irving, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reata Pharmaceuticals, Inc., Irving, TX, USA","institution_ids":["https://openalex.org/I143032186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Warren Huff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143032186","display_name":"Reata Pharmaceuticals (United States)","ror":"https://ror.org/02jqp5961","country_code":"US","type":"company","lineage":["https://openalex.org/I143032186"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Warren Huff","raw_affiliation_strings":["Reata Pharmaceuticals, Inc., Irving, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reata Pharmaceuticals, Inc., Irving, TX, USA","institution_ids":["https://openalex.org/I143032186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015693146","display_name":"Robin Kral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143032186","display_name":"Reata Pharmaceuticals (United States)","ror":"https://ror.org/02jqp5961","country_code":"US","type":"company","lineage":["https://openalex.org/I143032186"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Kral","raw_affiliation_strings":["Reata Pharmaceuticals, Inc., Irving, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reata Pharmaceuticals, Inc., Irving, TX, USA","institution_ids":["https://openalex.org/I143032186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019578505","display_name":"Karen T. Liby","orcid":"https://orcid.org/0000-0003-3317-3437","observed_orcids":["https://orcid.org/0000-0003-3317-3437"]},"institutions":[{"id":"https://openalex.org/I107672454","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22","country_code":"US","type":"education","lineage":["https://openalex.org/I107672454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen T. Liby","raw_affiliation_strings":["Dartmouth Medical School, Hanover, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dartmouth Medical School, Hanover, NH, USA","institution_ids":["https://openalex.org/I107672454"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108192090","display_name":"Michael B. Sporn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107672454","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22","country_code":"US","type":"education","lineage":["https://openalex.org/I107672454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Sporn","raw_affiliation_strings":["Dartmouth Medical School, Hanover, NH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dartmouth Medical School, Hanover, NH, USA","institution_ids":["https://openalex.org/I107672454"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":null,"fwci":0.107,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.43918819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"57","issue":"4","first_page":"B68","last_page":"B68"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11332","display_name":"Genomics, phytochemicals, and oxidative stress","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11332","display_name":"Genomics, phytochemicals, and oxidative stress","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bardoxolone-methyl","display_name":"bardoxolone methyl","score":0.9890000224113464},{"id":"https://openalex.org/keywords/keap1-nrf2-pathway","display_name":"Nrf2/Keap1 pathway","score":0.9259999990463257},{"id":"https://openalex.org/keywords/nrf2","display_name":"Nrf2","score":0.6610000133514404},{"id":"https://openalex.org/keywords/oleanolic-acid","display_name":"oleanolic acid","score":0.6669999957084656},{"id":"https://openalex.org/keywords/inflammation-induced-carcinogenesis","display_name":"inflammation-induced carcinogenesis","score":0.8569999933242798},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.5860000252723694},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.734000027179718},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.8090000152587891},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.8550000190734863},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9860000014305115},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6539999842643738},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7300000190734863},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5419999957084656},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.32100000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6441844701766968},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6196832656860352},{"id":"https://openalex.org/C2776529522","wikidata":"https://www.wikidata.org/wiki/Q18034700","display_name":"KEAP1","level":4,"score":0.6081086993217468},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4988274574279785},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.465656578540802},{"id":"https://openalex.org/C2778858181","wikidata":"https://www.wikidata.org/wiki/Q418628","display_name":"Oleanolic acid","level":3,"score":0.4594583809375763},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.4209122061729431},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32204192876815796},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29495930671691895},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23791348934173584},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.22212713956832886},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.21628832817077637},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13029423356056213},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08559635281562805},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1053/j.ajkd.2011.02.208","doi":"https://doi.org/10.1053/j.ajkd.2011.02.208","is_oa":false,"landing_page_url":"https://doi.org/10.1053/j.ajkd.2011.02.208","pdf_url":null,"source":{"id":"https://openalex.org/S18197459","display_name":"American Journal of Kidney Diseases","issn_l":"0272-6386","issn":["0272-6386","1523-6838"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Kidney Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376610098","https://openalex.org/W2597687498","https://openalex.org/W2401030213","https://openalex.org/W3030222012","https://openalex.org/W4416637279","https://openalex.org/W2161096223","https://openalex.org/W4250069416","https://openalex.org/W7095240997","https://openalex.org/W4388200850","https://openalex.org/W7134914194"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}